| Line Item | 2024-04-30 | Y/Y |
|---|---|---|
| Revenue | $1K | -74.1% |
| R&D Expense | $10K | -93.7% |
| SG&A Expense | $1.1M | +85.9% |
| Operating Income | -$1.2M | -48.6% |
| Interest Expense | $4K | -51.5% |
| Pre-tax Income | -$1.7M | -114.5% |
| Net Income | -$1.7M | -119.0% |
| EPS (Basic) | -$0.03 | -233.3% |
| EPS (Diluted) | -$0.03 | -233.3% |
| Line Item | 2024-04-30 | Y/Y |
|---|---|---|
| Current Assets | $15K | -62.7% |
| Total Assets | $15K | -62.7% |
| Current Liabilities | $848K | -23.0% |
| Total Liabilities | $848K | -23.0% |
| Stockholders' Equity | -$834K | +35.1% |
| Line Item | 2024-04-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$207K | +52.5% |
| Investing Cash Flow | -$27K | — |
| Financing Cash Flow | $190K | +374.4% |